Abstract:<h3 class="a-plus-plus">Abstract</h3> <p class="a-plus-plus">Over the last two decades, mass spectrometry imaging (MSI) has been increasingly employed to investigate the spatial distribution of a wide variety of molecules in complex biological samples. MSI has demonstrated its potential in numerous applications from drug discovery, disease state evaluation through proteomic and/or metabolomic studies. Significant technological and methodological advancements have addressed natural limitations of the techniques, <em class="a-plus-plus">i.e.</em>, increased spatial resolution, increased detection sensitivity especially for large molecules, higher throughput analysis and data management. One of the next major evolutions of MSI is linked to the introduction of imaging mass cytometry (IMC). IMC is a multiplexed method for tissue phenotyping, imaging signalling pathway or cell marker assessment, at sub-cellular resolution (1 μm). It uses MSI to simultaneously detect and quantify up to 30 different antibodies within a tissue section. The combination of MSI with other molecular imaging techniques can also provide highly relevant complementary information to explore new scientific fields. Traditionally, classical histology (especially haematoxylin and eosin–stained sections) is overlaid with molecular profiles obtained by MSI. Thus, MSI-based molecular histology provides a snapshot of a tissue microenvironment and enables the correlation of drugs, metabolites, lipids, peptides or proteins with histological/pathological features or tissue substructures. Recently, many examples combining MSI with other imaging modalities such as fluorescence, confocal Raman spectroscopy and MRI have emerged. For instance, brain pathophysiology has been studied using both MRI and MSI, establishing correlations between in and <em class="a-plus-plus">ex vivo</em> molecular imaging techniques. Endogenous metabolite and small peptide modulation were evaluated depending on disease state. Here, we review advanced ‘hot topics’ in MSI development and explore the combination of MSI with established molecular imaging techniques to improve our understanding of biological and pathophysiological processes.</p>

Challenges and Recent Advances in Quantitative Mass Spectrometry Imaging of Small Molecules

Quantitative Mass Spectrometry Imaging: Therapeutics & Biomolecules

A critical evaluation of the current state-of-the-art in quantitative imaging mass spectrometry

Quantitative mass spectrometry imaging (qMSI): A tutorial

Quantitative Mass Spectrometry Imaging with Liquid Microjunction Surface Sampling.

Mass Spectrometry Imaging: Applications in Drug Distribution Studies

From molecules to visuals: Empowering drug discovery and development with mass spectrometry imaging

Mass Spectrometry Imaging Techniques: Non-Ambient and Ambient Ionization Approaches

Recent advancement and applications of mass spectrometry imaging

Development of mass spectrometry imaging techniques and its latest applications

Postionization Mass Spectrometry Imaging: Past, Present, and Future

High spatial resolution mass spectrometry imaging for spatial metabolomics: Advances, challenges, and future perspectives

Recent advances in mass spectrometry imaging of single cells

Recent Advances in Ambient Mass Spectrometry Imaging

High-throughput mass spectrometry imaging of biological systems: Current approaches and future directions

Mass spectrometry imaging and its application in pharmaceutical research and development: A concise review

A vision for better health: mass spectrometry imaging for clinical diagnostics.

Updated Progress on Mass Spectrometry Imaging and its Application in Cancer Treatment and Drug Discovery

Next Generation of Mass Spectrometry Imaging: from Micrometer to Subcellular Resolution

Emerging Technologies in Mass Spectrometry Imaging

Mass Spectrometry Imaging and Integration with Other Imaging Modalities for Greater Molecular Understanding of Biological Tissues